BRDT and cancer: In addition to indicating that loss of ectopic BRDT expression due to shRNA knockdown in NCI-H2009 cells impairs xenograft-derived tumor growth, these data suggest proproliferative and/or anti-apoptotic functions for BRDT when it is ectopically expressed in cancer.